.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Teva
Citi
Healthtrust
Express Scripts
Federal Trade Commission
Merck
Chubb
US Army

Generated: June 22, 2017

DrugPatentWatch Database Preview

BALSALAZIDE DISODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Balsalazide Disodium, and what generic Balsalazide Disodium alternatives are available?

Balsalazide Disodium is a drug marketed by West-ward Pharms Int, Mylan, Par Pharm Inc, and Apotex Inc. and is included in four NDAs.

The generic ingredient in BALSALAZIDE DISODIUM is balsalazide disodium. There are ten drug master file entries for this compound. Thirteen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the balsalazide disodium profile page.

Summary for Tradename: BALSALAZIDE DISODIUM

Patents:0
Applicants:4
NDAs:4
Suppliers / Packagers: see list9
Bulk Api Vendors: see list96
Clinical Trials: see list152
Patent Applications: see list2,083
Drug Prices:see details
DailyMed Link:BALSALAZIDE DISODIUM at DailyMed

Pharmacology for Tradename: BALSALAZIDE DISODIUM

Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
BALSALAZIDE DISODIUM
balsalazide disodium
CAPSULE;ORAL077806-001Dec 28, 2007BXRXNoNo► Subscribe► Subscribe
Apotex Inc
BALSALAZIDE DISODIUM
balsalazide disodium
CAPSULE;ORAL077883-001Dec 28, 2007ABRXNoNo► Subscribe► Subscribe
Mylan
BALSALAZIDE DISODIUM
balsalazide disodium
CAPSULE;ORAL077807-001Dec 28, 2007ABRXNoNo► Subscribe► Subscribe
Par Pharm Inc
BALSALAZIDE DISODIUM
balsalazide disodium
TABLET;ORAL206336-001Sep 8, 2015ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
McKinsey
Queensland Health
Boehringer Ingelheim
Daiichi Sankyo
Mallinckrodt
UBS
Accenture
Covington
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot